Cognizant Technology Solutions (CTSH)
(Delayed Data from NSDQ)
$76.53 USD
-0.23 (-0.30%)
Updated Oct 3, 2024 03:59 PM ET
After-Market: $76.51 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$76.53 USD
-0.23 (-0.30%)
Updated Oct 3, 2024 03:59 PM ET
After-Market: $76.51 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Zacks News
Genpact Boosts AI Product Portfolio with TandemSeven Buyout
by Zacks Equity Research
Genpact (G) aims to enrich its AI based solutions portfolio through the acquisition of TandemSeven.
Cognizant Scales New 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Cognizant (CTSH) hits 52-week high driven by accretive acquisitions and its ability to capitalize on the ongoing digital transition.
Accenture Buys Financial Technology Consultancy Firm VERAX
by Zacks Equity Research
By integrating VERAX, Accenture (ACN) will not only get a large talent pool, but will also gain a huge customer base in Canada, thereby expanding its reach in different markets.
Cognizant (CTSH) Drives on Domain Expertise, Acquisitions
by Zacks Equity Research
Cognizant (CTSH) is benefiting from domain expertise, acquisitions and its ability to harness the ongoing digital transition. The raised FY17 EPS view aptly reflects these growth trends.
Top Analyst Reports for Biogen, Activision & Cigna
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Biogen (BIIB), Activision (ATVI), and Cigna (CI).
Cognizant (CTSH) Beats on Q2 Earnings, Guides Up '17 View (Revised)
by Zacks Equity Research
Cognizant's (CTSH) second-quarter 2017 results benefited from its significant exposure to the fast-growing verticals like Financial Services and Healthcare.
Cognizant (CTSH) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Cognizant (CTSH) reported strong second-quarter results driven by growth across all four domains.
What's in Store for Cognizant (CTSH) this Earnings Season?
by Zacks Equity Research
Cognizant's (CTSH) second quarter is anticipated to benefit from the company's growing expertise in delivering digital solutions. Accretive acquisitions have been a key catalyst in this regard.
Accenture (ACN) Closes Consultancy Firm LabAnswer Buyout
by Zacks Equity Research
Accenture Plc (ACN) recently announced that it has completed the acquisition of LabAnswer, a research and laboratory informatics technology consulting firm.
Genpact Cora to Enhance Enterprises' Digital Capabilities
by Zacks Equity Research
Genpact Limited (G) recently announced the launch of its artificial intelligence (AI) - based platform called Genpact Cora to help improve digital capabilities of enterprises.
Accenture Acquires Intrepid to Boost Digital Design Services
by Zacks Equity Research
In an effort to further enhance its digital design services, Accenture Plc (ACN) recently acquired Cambridge-based mobile design and development company ??? Intrepid.
Here's Why You Should Hold on to Accenture (ACN) Stock Now
by Zacks Equity Research
One stock that investors need to hold on to right now is Accenture plc (ACN). There are a few lingering concerns which are short-lived.
Accenture (ACN) Q3 Earnings and Revenue Surpass Estimates
by Zacks Equity Research
Accenture plc (ACN) reported better-than-expected third-quarter fiscal 2017 results.
Accenture, Microsoft Ink Deal to Create IDs Via Blockchain
by Zacks Equity Research
Accenture PLC (ACN) is joining forces with Microsoft Corporation (MSFT) to create digital ID databases for more than 1.1 billion people globally.
Is Accenture (ACN) Likely to Miss Q3 Earnings Estimates?
by Zacks Equity Research
Accenture Plc (ACN) is set to report third-quarter fiscal 2017 results on Jun 22.
Infosys (INFY) Weighed Down by Visa Scare, Weakening Sales
by Zacks Equity Research
Over the last few months, Infosys Limited (INFY) has grabbed headlines for all the wrong reasons.
Cognizant (CTSH) Up 11.1% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Accenture Continues Inorganic Growth with SolutionsIQ Buyout
by Zacks Equity Research
Accenture Plc (ACN) stated that it has now acquired SolutionsIQ.
Accenture to Buy LabAnswer, Expand Life Sciences Portfolio
by Zacks Equity Research
Accenture Plc (ACN) recently announced that it has entered into an agreement to acquire LabAnswer, a research and laboratory informatics technology consulting firm.
Company News for May 08, 2017
by Zacks Equity Research
Companies in the News are: ATVI,CI,CTSH,SHAK
Cognizant (CTSH) Q1 Earnings Beat Estimates, View Intact
by Zacks Equity Research
Cognizant Technology Solutions Corp.'s (CTSH) first-quarter 2017 adjusted earnings of 79 cents per share that beat the Zacks Consensus Estimate of 75 cents.
Cognizant (CTSH) Q1 Earnings & Revenues Increase Y/Y
by Zacks Equity Research
Cognizant Technology Solutions Corp (CTSH) reported non GAAP earnings of 84 cents a share, compared to 80 cents reported in the prior year quarter
Will Cognizant (CTSH) Pull Off a Surprise in Q1 Earnings?
by Zacks Equity Research
Cognizant Technology Solutions Corp. (CTSH) is set to report first-quarter 2017 results on May 5.
Infosys (INFY) Reports In-Line Q4 Earnings, Outlook Bleak
by Zacks Equity Research
Infosys (INFY) fourth-quarter fiscal 2017 earnings were in line with estimates, but revenues missed.
Accenture (ACN) Q2 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Accenture plc (ACN) reported mixed second-quarter fiscal 2017 results.